153 studies found for:    niaid hiv/aids | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
Condition: Human Immunodeficiency Virus
Intervention:
22 Not yet recruiting A Semi-Factorial Cluster-Randomized Trial to Estimate the Effect Size of Community Mobilization and VCT Vans on the Adoption of Voluntary Counseling and Testing (VCT) Services in Andhra Pradesh, India: THE MCVCT STUDY
Conditions: HIV;   AIDS;   Epidemiology;   Prevention
Intervention:
23 Recruiting Gene Expression in HIV and Tuberculosis Co-infection
Conditions: Tuberculosis;   HIV;   IRIS
Intervention:
24 Recruiting Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study
Condition: Immunodeficiency Virus, Human
Interventions: Drug: Aspirin 81 mg table;   Drug: Atorvastatin 40 mg
25 Recruiting HIV Accelerated Liver Disease in Uganda
Condition: Fibrosis
Intervention:
26 Recruiting Mycobacterial and Opportunistic Infections in HIV-Negative Thai and Taiwanese Patients Associated With Autoantibodies to Interferon-gamma
Conditions: Immunodeficiency;   Mycobacterial Infection;   Opportunistic Infection
Intervention:
27 Recruiting VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...
Conditions: HIV-1 Infection;   Neutralizing Antibody;   Monoclonal Antibody;   Viral Load;   HIV Antibodies
Intervention: Biological: VRC-HIVMAB060-00-AB
28 Recruiting Clinical Outcomes in Persons With HIV Acquired Early in Life
Conditions: HIV;   Childhood;   Natural History;   Cardiac;   ART
Intervention:
29 Recruiting Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
Conditions: Cardiovascular Disease;   HIV Infections
Intervention:
30 Recruiting Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Primary and Chronic HIV-Infected Patients
Condition: HIV Infections
Intervention:
31 Recruiting Studies of Blood and Reproductive Fluids in HIV-Infected and Non-HIV-Infected Persons
Condition: HIV Infection
Intervention:
32 Recruiting Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans
Condition: HIV
Intervention:
33 Recruiting Viral Load in Blood and Lymph Tissues of HIV-Infected Individuals
Conditions: HIV Infection;   Viremia
Intervention:
34 Recruiting Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults
Conditions: HIV Infection;   Monoclonal Antibody, Human;   HIV Antibodies;   VRC01 Monoclonal Antibody;   Neutralizing Antibody
Intervention: Drug: VRC-HIVMAB060-00-AB
35 Recruiting Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers
Conditions: Healthy Volunteer;   HIV Vaccine
Interventions: Biological: Ad4-mgag;   Biological: Ad4-EnvC150
36 Recruiting Leukapheresis for Research on HCV-Coinfected Patients
Conditions: Hepatitis C;   HIV Infections
Intervention:
37 Recruiting PET Imaging and Lymph Node Assessment of IRIS in People With AIDS
Condition: Immune Reconstitution Inflammatory Syndrome
Intervention:
38 Recruiting The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers
Condition: HIV
Interventions: Drug: Ritonavir;   Drug: Cobicistat
39 Recruiting The HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial
Condition: Rapid HIV Screening
Interventions: Other: A: Nontargeted rapid HIV screening;   Other: B: Enhanced targeted rapid HIV screening;   Other: C: Traditional targeted rapid HIV screening
40 Not yet recruiting Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa
Condition: HIV Infections
Interventions: Biological: DNA-HIV-PT123 vaccine;   Biological: NYVAC-HIV-PT1 vaccine;   Biological: NYVAC-HIV-PT4 vaccine;   Biological: AIDSVAX B/E vaccine;   Biological: Placebo for DNA/NYVAC/AIDSVAX

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years